Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • At a satellite symposium at the South African AIDS Conference linked to a publication in The Lancet, the ECHO trial of contraceptive use and impact on HIV risk released its results. The topline finding: There was no substantial difference in HIV risk among women using DMPA-IM, the LNG implant or the copper IUD.

    June 13, 2019
    AVAC
  • The results of the ECHO Study (Evidence for Contraceptive Options in HIV Outcomes)—a trial designed look at whether three specific contraceptive methods (DMPA-IM, the Jadelle Implant and the Copper IUD) impact women’s HIV risk—will be announced on Thursday, June 13, 14:00–15:30 (South Africa Time) at the South Africa AIDS Conference in Durban.

    June 7, 2019
    AVAC
  • First, the HIV Prevention Market Manager project will present findings from research on what encourages or discourages the effective use of HIV prevention among adolescent girls and young women. And join us to discuss "vaccine hesitancy" and its implications across global health.

    May 20, 2019
    HIV Vaccine, General
    AVAC
  • This HIV Vaccine Awareness Day, Mitchell Warren talks about this promising and perilous time for vaccines. AVAC has an updated toolkit of resources for translating HIV vaccine research with a renewed sense of urgency. And we invite you to join our vaccine focused webinars.

    May 17, 2019
    Mitchell Warren
  • This HVAD, AVAC has an updated toolkit of resources for translating HIV vaccine research with a renewed sense of urgency, and two dedicated hashtags to rally the call on social media: #HIVvaccineAware and #HVAD2019. We hope you’ll join the conversation!

    May 15, 2019
    Antibody Related Research, HIV Vaccine
    AVAC
  • In early May, AVAC joined Zambian civil society organizations for a kick-off meeting to plan the country’s Key Population Investment Fund activities. The lessons learned there are highly relevant to civil society in every country where KPIF will be introduced. This is time sensitive and urgent for all of us who want to see this investment have a meaningful impact.

    May 14, 2019
    General
    AVAC
  • Gilead’s donation is an acknowledgment that there is a huge issue with PrEP access in America, as in many parts of the world. We welcome this indication that the company grasps the gravity of the situation. However, we urgently need a lower price for all. It’s disappointing that even this small step has taken so long.

    May 14, 2019
    Mitchell Warren
  • Cleopatra Shiella Makura writes about the importance of tailoring sexual and reproductive health information for younger audiences.

    May 13, 2019
    General
    Cleopatra Shiella Makura
  • The field is on the brink of yet another HIV Vaccine Awareness Day on May 18. To mark the day, we hope you will join us for webinars on May 16 and on May 23 to explore the two themes at the top of our minds here at AVAC this HVAD.

    May 10, 2019
    AVAC
  • AVAC is pleased to announce the next offering of its global Good Participatory Practice Online Training Course! This course offering will run May 29 through August 2, 2019.

    May 8, 2019
    General
    AVAC

Pages